Altria Group Inc. Stock
€44.99
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Altria Group
sharewise wants to provide you with the best news and tools for Altria Group, so we directly link to the best financial data sources.
Financials
News
Altria and NJOY Respond to ITC Initial Determination in Complaint Against NJOY
Altria Group, Inc. (NYSE: MO) and its operating company NJOY today respond to the U.S. International Trade Commission (ITC) Administrative Law Judge’s (ALJ) initial determination regarding the
Altria Increases Quarterly Dividend by 4.1% to $1.02 Per Share
Altria Group, Inc. (NYSE: MO) today announced that our Board of Directors voted to increase our regular quarterly dividend by 4.1% to $1.02 per share versus the previous rate of $0.98 per share
Altria Reports 2024 Second-Quarter and First-Half Results; Narrows 2024 Full-Year Earnings Guidance
Altria Group, Inc. (NYSE: MO) today reports our 2024 second-quarter and first-half business results and narrows our guidance for 2024 full-year adjusted diluted earnings per share (EPS).
Altria to Host Webcast of 2024 Second-Quarter and First-Half Results
Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Wednesday, July 31, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 second-quarter and first-half business results
Altria Announces PMTA Submission for on! PLUS™ Nicotine Pouches
Today, Altria Group, Inc. (Altria) announces the submission of Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration (FDA) for its innovative on! PLUS oral
NJOY Receives First FDA Authorizations for Menthol E-Vapor Products
Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food and Drug Administration (FDA) issued marketing orders for NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY
NJOY Submits Premarket Tobacco Product Applications to the FDA for NJOY ACE 2.0 Featuring Bluetooth®-enabled Access Restriction Technology
Today, NJOY, an Altria company, announces the submission of a supplemental Premarket Tobacco Product Application (PMTA) to the U.S. Food and Drug Administration (FDA) to commercialize and market
Altria Holds 2024 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $0.98 Per Share
Altria Group, Inc. (Altria) (NYSE: MO) held our 2024 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria’s Chief Executive Officer, provided
Altria to Host Webcast of 2024 Annual Meeting of Shareholders
Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast of its 2024 Annual Meeting of Shareholders (“2024 Annual Meeting” or “meeting”) on Thursday, May 16, 2024 at 9:00 a.m. Eastern
Altria Reports 2024 First-Quarter Results; Reaffirms Full-Year Guidance
Altria Group, Inc. (NYSE: MO) today reports our 2024 first-quarter business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS).
“We made meaningful
Altria to Host Webcast of 2024 First-Quarter Results
Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Thursday, April 25, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 first-quarter business results. Altria will issue a
Altria Enters $2.4 Billion Accelerated Share Repurchase Transactions in Connection with Closing of Offering of Anheuser-Busch InBev Stock
Altria Group, Inc. (Altria) (NYSE: MO) today announces that we entered accelerated share repurchase (ASR) transactions under separate agreements with Morgan Stanley & Co. LLC and Goldman Sachs &